The Sound Of Silence: FDA Ponders How To Label When No Subgroup Difference Found
This article was originally published in The Pink Sheet Daily
Executive Summary
Clinical trial diversity meeting may broach the subject of whether drug labels should indicate that subgroup differences were explored, but none found.